Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Kevin Caliendo maintains UnitedHealth Group (NYSE:UNH) with a Buy and raises the price target from $378 to $430.
RBC Capital analyst Ben Hendrix maintains UnitedHealth Group (NYSE:UNH) with a Outperform and raises the price target from $...
Piper Sandler analyst Jessica Tassan maintains UnitedHealth Group (NYSE:UNH) with a Overweight and lowers the price target f...
Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech...
UnitedHealth Group Inc (UNH) reported strong earnings, giving David Tepper and Michael Burry led hedge funds hope for the future.
(Editor’s note: The future prices of benchmark tracking ETFs, latest earnings, and the headline were updated in the story.) ...
UnitedHealth stock rises after Q3 earnings beat expectations and the company lifts its 2025 guidance, signaling confidence in f...
- Reuters Citing Conf Call
